601089 福元医药
交易中 07-01 14:17:57
资讯
新帖
简况
6月29日福元医药涨6.84%,农银医疗保健股票基金重仓该股
证券之星 · 06-29 16:31
6月29日福元医药涨6.84%,农银医疗保健股票基金重仓该股
福元医药最新公告:匹维溴铵片通过一致性评价
证券之星 · 06-24
福元医药最新公告:匹维溴铵片通过一致性评价
股市必读:福元医药(601089)6月18日披露最新机构调研信息
证券之星 · 06-22
股市必读:福元医药(601089)6月18日披露最新机构调研信息
【机构调研记录】长盛基金调研福元医药、金橙子
证券之星 · 06-19
【机构调研记录】长盛基金调研福元医药、金橙子
福元医药:有知名机构淡水泉参与的多家机构于6月17日调研我司
证券之星 · 06-18
福元医药:有知名机构淡水泉参与的多家机构于6月17日调研我司
福元医药最新公告:克立硼罗软膏获药品注册证书
证券之星 · 06-16
福元医药最新公告:克立硼罗软膏获药品注册证书
福元医药最新公告:苯溴马隆片获药品注册证书
证券之星 · 06-16
福元医药最新公告:苯溴马隆片获药品注册证书
福元医药:坚持以稳健的经营业绩为基础
证券之星 · 06-08
福元医药:坚持以稳健的经营业绩为基础
福元医药(601089.SH):甲巯咪唑片获得药品注册证书
智通财经 · 06-01
福元医药(601089.SH):甲巯咪唑片获得药品注册证书
福元医药(601089)披露2025年年度权益分派实施公告,5月26日股价下跌1.47%
证券之星 · 05-26
福元医药(601089)披露2025年年度权益分派实施公告,5月26日股价下跌1.47%
每周股票复盘:福元医药(601089)氯吡格雷阿司匹林片获注册证
证券之星 · 05-24
每周股票复盘:福元医药(601089)氯吡格雷阿司匹林片获注册证
福元医药(601089.SH):氯吡格雷阿司匹林片获得药品注册证书
智通财经 · 05-21
福元医药(601089.SH):氯吡格雷阿司匹林片获得药品注册证书
福元医药最新公告:奥美沙坦酯口崩片获药品注册证书
证券之星 · 05-07
福元医药最新公告:奥美沙坦酯口崩片获药品注册证书
每周股票复盘:福元医药(601089)一季度营收利润下降因集采未中标及研发增加
证券之星 · 05-02
每周股票复盘:福元医药(601089)一季度营收利润下降因集采未中标及研发增加
股市必读:福元医药(601089)4月29日披露最新机构调研信息
证券之星 · 04-30
股市必读:福元医药(601089)4月29日披露最新机构调研信息
福元医药(601089)2026年一季报简析:净利润同比下降26.96%
证券之星 · 04-26
福元医药(601089)2026年一季报简析:净利润同比下降26.96%
图解福元医药一季报:第一季度单季净利润同比下降26.96%
证券之星 · 04-24
图解福元医药一季报:第一季度单季净利润同比下降26.96%
4月24日福元医药跌5.34%,农银医疗保健股票基金重仓该股
证券之星 · 04-24
4月24日福元医药跌5.34%,农银医疗保健股票基金重仓该股
福元医药最新公告:布瑞哌唑原料药获上市申请批准
证券之星 · 04-23
福元医药最新公告:布瑞哌唑原料药获上市申请批准
股市必读:福元医药(601089)4月21日披露最新机构调研信息
证券之星 · 04-22
股市必读:福元医药(601089)4月21日披露最新机构调研信息
加载更多
公司概况
公司名称:
北京福元医药股份有限公司
所属行业:
医药制造业
上市日期:
2022-06-30
主营业务:
北京福元医药股份有限公司的主营业务是药品及医疗器械研发、生产和销售。公司的主要产品是心血管类药品、糖尿病类药品、慢性肾病类药品、消化系统类药品、皮肤病类药品、神经精神系统类药品、妇科类药品、医疗器械。公司是国家认定的高新技术企业,已入选北京医药产业跨越发展工程G20企业,荣列中国药品研发综合实力百强、北京民营企业科技创新百强,中国化药研发实力五十强,建有国家级博士后科研工作站、北京市企业技术中心,通过国家级智能制造能力成熟度三级认证,被评为国家级绿色工厂。
发行价格:
14.62
{"stockData":{"symbol":"601089","market":"SH","secType":"STK","nameCN":"福元医药","latestPrice":17.16,"timestamp":1782886677000,"preClose":16.28,"halted":0,"volume":5048400,"delay":0,"changeRate":0.0541,"floatShares":480000000,"shares":480000000,"eps":0.9045,"marketStatus":"交易中","change":0.88,"latestTime":"07-01 14:17:57","open":16.02,"high":17.2,"low":15.81,"amount":83467700,"amplitude":0.0854,"askPrice":17.16,"askSize":36,"bidPrice":17.15,"bidSize":173,"shortable":0,"etf":0,"ttmEps":0.9045,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1782889200000},"marketStatusCode":2,"adr":0,"adjPreClose":16.28,"symbolType":"stock","openAndCloseTimeList":[[1782869400000,1782876600000],[1782882000000,1782889200000]],"highLimit":17.91,"lowLimit":14.65,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":480000000,"isCdr":false,"pbRate":2.02,"roa":"--","peRate":18.971808,"roe":"2.49%","epsLYR":1,"committee":-0.203065,"marketValue":8237000000,"turnoverRate":0.0105,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-07-02。","floatMarketCap":8237000000},"requestUrl":"/m/hq/s/601089/","defaultTab":"news","newsList":[{"id":"2647324156","title":"6月29日福元医药涨6.84%,农银医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647324156","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647324156?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:31","pubTimestamp":1782721872,"startTime":"0","endTime":"0","summary":"证券之星消息,6月29日福元医药涨6.84%创60日新低,收盘报16.71元,换手率1.35%,成交量6.5万手,成交额1.06亿元。重仓福元医药的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共6家,其中持有数量最多的公募基金为农银汇理基金的农银医疗保健股票。该公募基金现任基金经理为梦圆。农银医疗保健股票的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","601089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645896854","title":"福元医药最新公告:匹维溴铵片通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2645896854","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645896854?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:52","pubTimestamp":1782291121,"startTime":"0","endTime":"0","summary":"福元医药(601089.SH)公告称,公司收到国家药监局颁发的匹维溴铵片(规格:50mg)《药品补充申请批准通知书》,批准该药品通过仿制药质量和疗效一致性评价。该药品适用于对症治疗与肠道功能紊乱有关的疼痛、排便异常和胃肠不适等。截至公告日,公司累计研发投入825.92万元。2025年该药品在中国三大终端六大市场销售额约4.44亿元。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400030403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601089","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645001679","title":"股市必读:福元医药(601089)6月18日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2645001679","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645001679?lang=zh_cn&edition=full","pubTime":"2026-06-22 05:16","pubTimestamp":1782076575,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,福元医药报收于16.77元,上涨0.24%,换手率0.83%,成交量4.0万手,成交额6731.71万元。FY103注射液目前已开展I期临床,已启动入组和给药。公司已有23个品种中标国家带量采购;第十批集采中复方α-酮酸片未中标,叠加省续标影响致2025年及2026年一季度营收利润承压;第十一批集采中标6个产品,其中4个此前未在国内销售;正积极准备第十二批集采投标及中标后市场应对。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200001781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","601089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644032118","title":"【机构调研记录】长盛基金调研福元医药、金橙子","url":"https://stock-news.laohu8.com/highlight/detail?id=2644032118","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644032118?lang=zh_cn&edition=full","pubTime":"2026-06-19 08:01","pubTimestamp":1781827311,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及6月18日披露的机构调研信息,长盛基金近期对2家上市公司进行了调研,相关名单如下:1)福元医药 调研纪要:截至2025年底,公司研发人员407人,核心技术人员具有国际化研发背景。2025年研发费用4亿元左右,创新药投入占比将逐步提升。业绩承诺方承诺2026至2028年度净利润分别不低于3,066.96万元、3,338.44万元、3,663.09万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061900004916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0231","BK0239","688291","601089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644702027","title":"福元医药:有知名机构淡水泉参与的多家机构于6月17日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2644702027","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644702027?lang=zh_cn&edition=full","pubTime":"2026-06-18 18:31","pubTimestamp":1781778680,"startTime":"0","endTime":"0","summary":"此外,公司正在积极布局药品及医疗器械电商业务,进一步扩大公司的零售市场。福元医药主营业务:药品制剂及医疗器械的研发、生产和销售。福元医药2026年一季报显示,一季度公司主营收入8.11亿元,同比下降2.32%;归母净利润9541.19万元,同比下降26.96%;扣非净利润8950.01万元,同比下降26.72%;负债率21.19%,投资收益517.19万元,财务费用6.92万元,毛利率61.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800033261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","601089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643758951","title":"福元医药最新公告:克立硼罗软膏获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2643758951","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643758951?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:28","pubTimestamp":1781602088,"startTime":"0","endTime":"0","summary":"福元医药(601089.SH)公告称,公司收到国家药监局颁发的克立硼罗软膏《药品注册证书》,批准该药品生产。该药品适用于3月龄及以上轻度至中度特应性皮炎患者的局部外用治疗,视同通过一致性评价。截至公告日,公司累计研发投入710.65万元。2025年该药品在中国三大终端六大市场销售额约1.71亿元。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600030621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","601089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643775899","title":"福元医药最新公告:苯溴马隆片获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2643775899","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643775899?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:27","pubTimestamp":1781602061,"startTime":"0","endTime":"0","summary":"福元医药(601089.SH)公告称,公司近日收到国家药监局颁发的苯溴马隆片(规格:50mg)《药品注册证书》,批准该药品生产。该药品适用于原发性高尿酸血症及痛风性关节炎间歇期,视同通过一致性评价。截至公告日,公司累计研发投入553.08万元。2025年该药品在三大终端六大市场销售额约4.28亿元。此次获证将丰富公司产品线,但销售受政策及市场环境影响,存在不确定性。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600030620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","601089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641044521","title":"福元医药:坚持以稳健的经营业绩为基础","url":"https://stock-news.laohu8.com/highlight/detail?id=2641044521","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641044521?lang=zh_cn&edition=full","pubTime":"2026-06-08 15:51","pubTimestamp":1780905076,"startTime":"0","endTime":"0","summary":"证券之星消息,福元医药06月08日在投资者关系平台上答复投资者关心的问题。公司充分理解投资者对公司股价表现的关注。公司会坚持以稳健的经营业绩为基础,持续通过提升研发的创新与管理能力,提升营销效率和市场响应速度,优化管理保障产能,打造三位一体的核心竞争优势,保障公司稳健发展。后续公司将继续加强与投资者的沟通,及时传递经营动态,增进投资者对公司价值的理解与认可。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800017179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","601089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640931926","title":"福元医药(601089.SH):甲巯咪唑片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640931926","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640931926?lang=zh_cn&edition=full","pubTime":"2026-06-01 15:47","pubTimestamp":1780300046,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福元医药(601089.SH)发布公告,近日,公司收到了国家药品监督管理局颁发的甲巯咪唑片(规格:5mg;10mg)(简称“该药品”)《药品注册证书》,批准该药品生产。该药品适用于甲状腺功能亢进症等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448437.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601089","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638054310","title":"福元医药(601089)披露2025年年度权益分派实施公告,5月26日股价下跌1.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638054310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638054310?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:43","pubTimestamp":1779806596,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘,福元医药报收于18.79元,较前一交易日下跌1.47%,最新总市值为90.19亿元。该股当日开盘19.11元,最高19.23元,最低18.7元,成交额达5461.98万元,换手率为0.6%。近日,福元医药发布《2025年年度权益分派实施公告》:每股现金红利0.5元(含税),股权登记日为2026年6月1日,除权(息)日为2026年6月2日,现金红利发放日为2026年6月2日。个人股东持股期限不同,税负分别为20%、10%或免税;QFII及沪港通投资者按10%税率代扣税,每股实发0.45元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","601089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637637584","title":"每周股票复盘:福元医药(601089)氯吡格雷阿司匹林片获注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2637637584","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637637584?lang=zh_cn&edition=full","pubTime":"2026-05-24 03:18","pubTimestamp":1779563893,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,福元医药报收于18.8元,较上周的19.98元下跌5.91%。本周,福元医药5月18日盘中最高价报19.97元。本周关注点公司公告汇总:氯吡格雷阿司匹林片获药品注册证书,视同通过一致性评价。公司公告汇总北京福元医药股份有限公司近日收到国家药品监督管理局颁发的氯吡格雷阿司匹林片《药品注册证书》,批准该药品生产。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","601089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637389674","title":"福元医药(601089.SH):氯吡格雷阿司匹林片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2637389674","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637389674?lang=zh_cn&edition=full","pubTime":"2026-05-21 17:27","pubTimestamp":1779355678,"startTime":"0","endTime":"0","summary":"智通财经APP讯, 福元医药(601089.SH)发布公告,近日,公司收到了国家药品监督管理局(以下简称“国家药监局”)颁发的氯吡格雷阿司匹林片[规格:每片含硫酸氢氯吡格雷75mg(按C₁₆H₁₆ClNO₂S计)与阿司匹林100mg]《药品注册证书》(证书编号:2026S01570),批准该药品生产。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"福元医药(601089.SH):氯吡格雷阿司匹林片获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601089","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633433571","title":"福元医药最新公告:奥美沙坦酯口崩片获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2633433571","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633433571?lang=zh_cn&edition=full","pubTime":"2026-05-07 18:49","pubTimestamp":1778150995,"startTime":"0","endTime":"0","summary":"福元医药(601089.SH)公告称,公司近日收到国家药监局颁发的奥美沙坦酯口崩片(规格10mg;20mg)《药品注册证书》,批准该药品生产。该药品适用于高血压的治疗,原研药暂未在国内上市,本次获批视同通过一致性评价。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700034197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601089","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623291","title":"每周股票复盘:福元医药(601089)一季度营收利润下降因集采未中标及研发增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623291","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632623291?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:25","pubTimestamp":1777674312,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,福元医药报收于20.59元,较上周的20.91元下跌1.53%。本周,福元医药4月28日盘中最高价报21.07元。答:营业收入与利润总额下降的主要原因1、公司产品复方a-酮酸片产品集采未中标,以及中标产品受省集采续标影响,致使销量和价格同比下降。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631152143","title":"股市必读:福元医药(601089)4月29日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2631152143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631152143?lang=zh_cn&edition=full","pubTime":"2026-04-30 04:50","pubTimestamp":1777495809,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘,福元医药报收于20.49元,下跌0.73%,换手率0.52%,成交量2.49万手,成交额5139.44万元。当日关注点来自交易信息汇总:4月29日主力资金净流出604.28万元,占总成交额11.76%。机构调研要点公司目前生产经营稳定、正常有序。FY101注射液正在开展I期临床试验,当前实验效果达到预期目标,后续将按计划启动II期临床试验,并依照信息披露规定及时公告进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000015293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","601089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630807990","title":"福元医药(601089)2026年一季报简析:净利润同比下降26.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630807990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630807990?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:10","pubTimestamp":1777155024,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期福元医药发布2026年一季报。根据财报显示,福元医药净利润同比下降26.96%。截至本报告期末,公司营业总收入8.11亿元,同比下降2.32%,归母净利润9541.19万元,同比下降26.96%。去年的净利率为13.45%,算上全部成本后,公司产品或服务的附加值高。持有福元医药最多的基金为农银医疗保健股票,目前规模为11.42亿元,最新净值1.592,较上一交易日下跌0.12%,近一年上涨4.41%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600002909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629812299","title":"图解福元医药一季报:第一季度单季净利润同比下降26.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629812299","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629812299?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:54","pubTimestamp":1777024454,"startTime":"0","endTime":"0","summary":"证券之星消息,福元医药2026年一季报显示,一季度公司主营收入8.11亿元,同比下降2.32%;归母净利润9541.19万元,同比下降26.96%;扣非净利润8950.01万元,同比下降26.72%;负债率21.19%,投资收益517.19万元,财务费用6.92万元,毛利率61.7%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400054025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629161308","title":"4月24日福元医药跌5.34%,农银医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629161308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629161308?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:24","pubTimestamp":1777019091,"startTime":"0","endTime":"0","summary":"证券之星消息,4月24日福元医药跌5.34%创60日新低,收盘报20.91元,换手率1.73%,成交量8.3万手,成交额1.76亿元。重仓福元医药的公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共6家,其中持有数量最多的公募基金为农银汇理基金的农银医疗保健股票。该公募基金现任基金经理为梦圆。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400049635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601089","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629280886","title":"福元医药最新公告:布瑞哌唑原料药获上市申请批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2629280886","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629280886?lang=zh_cn&edition=full","pubTime":"2026-04-23 16:37","pubTimestamp":1776933425,"startTime":"0","endTime":"0","summary":"福元医药(601089.SH)公告称,公司近日收到国家药监局核准签发的布瑞哌唑原料药《化学原料药上市申请批准通知书》。该原料药用于治疗成人精神分裂症,此前技术审评申请已获受理,目前在CDE原辅包登记信息平台状态为“A”。此次获批将进一步丰富公司产品线,促进公司持续、稳定、健康发展。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300045323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601089","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629205070","title":"股市必读:福元医药(601089)4月21日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2629205070","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629205070?lang=zh_cn&edition=full","pubTime":"2026-04-22 04:25","pubTimestamp":1776803112,"startTime":"0","endTime":"0","summary":"截至2026年4月21日收盘,福元医药报收于22.11元,下跌0.63%,换手率0.55%,成交量2.65万手,成交额5881.77万元。来自:FY101注射液正按计划推进I期临床试验,实验效果符合公司预期。FY101注射液正在推进I期临床实验,实验效果达到预期;FY103注射液于2025年末获境内IND受理。中东局势动荡未对公司生产经营造成直接影响,主营业务集中于国内市场。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200010623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","601089"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782886682890,"stockEarnings":[{"period":"1week","weight":-0.0286},{"period":"1month","weight":-0.0913},{"period":"3month","weight":-0.3145},{"period":"6month","weight":-0.3034},{"period":"1year","weight":0.0024},{"period":"ytd","weight":-0.3034}],"compareEarnings":[{"period":"1week","weight":-0.0029},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.0369},{"period":"6month","weight":0.0316},{"period":"1year","weight":0.1887},{"period":"ytd","weight":0.0316}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京福元医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"18753人(较上一季度减少0.22%)","perCapita":"25595股","listingDate":"2022-06-30","address":"北京市通州区通州工业开发区广源东街8号","registeredCapital":"48000万元","survey":" 北京福元医药股份有限公司的主营业务是药品及医疗器械研发、生产和销售。公司的主要产品是心血管类药品、糖尿病类药品、慢性肾病类药品、消化系统类药品、皮肤病类药品、神经精神系统类药品、妇科类药品、医疗器械。公司是国家认定的高新技术企业,已入选北京医药产业跨越发展工程G20企业,荣列中国药品研发综合实力百强、北京民营企业科技创新百强,中国化药研发实力五十强,建有国家级博士后科研工作站、北京市企业技术中心,通过国家级智能制造能力成熟度三级认证,被评为国家级绿色工厂。","listedPrice":14.62},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福元医药(601089)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福元医药(601089)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福元医药,601089,福元医药股票,福元医药股票老虎,福元医药股票老虎国际,福元医药行情,福元医药股票行情,福元医药股价,福元医药股市,福元医药股票价格,福元医药股票交易,福元医药股票购买,福元医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福元医药(601089)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福元医药(601089)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}